Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Appointed director
Quarterly results
|
|
Mirati Therapeutics, Inc. (MRTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/16/2023 |
SC 13D/A
| Boxer Capital, LLC reports a 15.9% stake in Mirati Therapeutics, Inc. |
| 10/30/2020 |
SC 13D/A
| Boxer Capital, LLC reports a 18.9% stake in Mirati Therapeutics, Inc. |
| 02/14/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/04/2019 |
SC 13D/A
| BAKER BROS. ADVISORS LP reports a 5% stake in Mirati Therapeutics, Inc. |
| 07/30/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/19/2019 |
SC 13D/A
| Boxer Capital, LLC reports a 18.6% stake in Mirati Therapeutics, Inc. |
| 11/20/2017 |
SC 13D/A
| BAKER BROS. ADVISORS LP reports a 10% stake in Mirati Therapeutics, Inc. |
| 11/20/2017 |
SC 13D/A
| Boxer Capital, LLC reports a 16.9% stake in Mirati Therapeutics, Inc. |
| 06/27/2017 |
SC 13D/A
| Boxer Capital, LLC reports a 16.6% stake in Mirati Therapeutics, Inc. |
| 01/30/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 01/10/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 09/28/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 06/24/2016 |
SC 13D/A
| Mirati Therapeutics, Inc. reports a 14.5% stake in Mirati Therapeutics, Inc. |
| 06/08/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 03/17/2016 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
|
|